These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 24735817)
1. Aptamers targeting rabies virus-infected cells inhibit street rabies virus in vivo. Liang HR; Hu GQ; Li L; Gao YW; Yang ST; Xia XZ Int Immunopharmacol; 2014 Aug; 21(2):432-8. PubMed ID: 24735817 [TBL] [Abstract][Full Text] [Related]
2. Aptamers targeting rabies virus-infected cells inhibit viral replication both in vitro and in vivo. Liang HR; Liu Q; Zheng XX; Gai WW; Xue XH; Hu GQ; Wu HX; Wang HL; Yang ST; Xia XZ Virus Res; 2013 May; 173(2):398-403. PubMed ID: 23333291 [TBL] [Abstract][Full Text] [Related]
3. Selection of an aptamer against rabies virus: a new class of molecules with antiviral activity. Liang HR; Hu GQ; Xue XH; Li L; Zheng XX; Gao YW; Yang ST; Xia XZ Virus Res; 2014 May; 184():7-13. PubMed ID: 24486485 [TBL] [Abstract][Full Text] [Related]
4. Isolation of ssDNA aptamers that inhibit rabies virus. Liang HR; Hu GQ; Zhang T; Yang YJ; Zhao LL; Qi YL; Wang HL; Gao YW; Yang ST; Xia XZ Int Immunopharmacol; 2012 Nov; 14(3):341-7. PubMed ID: 22771543 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of rabies virus multiplication by siRNA delivered through adenoviral vector in vitro in BHK-21 cells and in vivo in mice. Sonwane AA; Dahiya SS; Saini M; Chaturvedi VK; Singh RP; Gupta PK Res Vet Sci; 2012 Aug; 93(1):498-503. PubMed ID: 21767857 [TBL] [Abstract][Full Text] [Related]
6. Reevaluation of the efficacy of favipiravir against rabies virus using in vivo imaging analysis. Yamada K; Noguchi K; Kimitsuki K; Kaimori R; Saito N; Komeno T; Nakajima N; Furuta Y; Nishizono A Antiviral Res; 2019 Dec; 172():104641. PubMed ID: 31672666 [TBL] [Abstract][Full Text] [Related]
8. λ-Carrageenan P32 Is a Potent Inhibitor of Rabies Virus Infection. Luo Z; Tian D; Zhou M; Xiao W; Zhang Y; Li M; Sui B; Wang W; Guan H; Chen H; Fu ZF; Zhao L PLoS One; 2015; 10(10):e0140586. PubMed ID: 26465753 [TBL] [Abstract][Full Text] [Related]
9. Design of future rabies biologics and antiviral drugs. Smith TG; Wu X; Franka R; Rupprecht CE Adv Virus Res; 2011; 79():345-63. PubMed ID: 21601054 [TBL] [Abstract][Full Text] [Related]
10. Small interfering RNAs targeting the rabies virus nucleoprotein gene. Yang YJ; Zhao PS; Zhang T; Wang HL; Liang HR; Zhao LL; Wu HX; Wang TC; Yang ST; Xia XZ Virus Res; 2012 Oct; 169(1):169-74. PubMed ID: 22884777 [TBL] [Abstract][Full Text] [Related]
11. β-d-N Konishi K; Kusakabe S; Kawaguchi N; Shishido T; Ito N; Harada M; Inoue S; Maeda K; Hall WW; Orba Y; Sawa H; Sasaki M; Sato A Antiviral Res; 2024 Sep; 229():105977. PubMed ID: 39089332 [TBL] [Abstract][Full Text] [Related]
12. Re-evaluating the effect of Favipiravir treatment on rabies virus infection. Banyard AC; Mansfield KL; Wu G; Selden D; Thorne L; Birch C; Koraka P; Osterhaus ADME; Fooks AR Vaccine; 2019 Aug; 37(33):4686-4693. PubMed ID: 29132993 [TBL] [Abstract][Full Text] [Related]
13. [The antiviral activity of RNAse Bacillus intermedius in experiments with mice preinfected with street rabies virus]. Gribencha SV; Potselueva LA; Barinskiĭ IF; Balandin TG; Deev SM; Leshchinskaia IB Vopr Virusol; 2004; 49(6):38-41. PubMed ID: 15597960 [TBL] [Abstract][Full Text] [Related]
14. Live attenuated rabies virus co-infected with street rabies virus protects animals against rabies. Wu X; Franka R; Henderson H; Rupprecht CE Vaccine; 2011 Jun; 29(25):4195-201. PubMed ID: 21514343 [TBL] [Abstract][Full Text] [Related]
15. Effects of cytosine arabinoside, adenine arabinoside, and 6-azauridine on rabies virus in vitro and in vivo. Harmon MW; Janis B J Infect Dis; 1976 Jan; 133(1):7-13. PubMed ID: 1245759 [TBL] [Abstract][Full Text] [Related]
16. Ribavirin-related compounds exert in vitro inhibitory effects toward rabies virus. Anindita PD; Sasaki M; Okada K; Ito N; Sugiyama M; Saito-Tarashima N; Minakawa N; Shuto S; Otsuguro S; Ichikawa S; Matsuda A; Maenaka K; Orba Y; Sawa H Antiviral Res; 2018 Jun; 154():1-9. PubMed ID: 29601893 [TBL] [Abstract][Full Text] [Related]
17. Status of antiviral therapeutics against rabies virus and related emerging lyssaviruses. Du Pont V; Plemper RK; Schnell MJ Curr Opin Virol; 2019 Apr; 35():1-13. PubMed ID: 30753961 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of antiviral activity of phenolic compounds and derivatives against rabies virus. Chávez JH; Leal PC; Yunes RA; Nunes RJ; Barardi CR; Pinto AR; Simões CM; Zanetti CR Vet Microbiol; 2006 Aug; 116(1-3):53-9. PubMed ID: 16697126 [TBL] [Abstract][Full Text] [Related]
19. [The antiviral activity of the peptide immunomodulator "Gepon" in experimental models of street rabies virus]. Gribencha SV; Kholms RD; Ataullakhanov RI; Barinskiĭ IF Vopr Virusol; 2003; 48(4):40-4. PubMed ID: 12945207 [TBL] [Abstract][Full Text] [Related]
20. [Inactivation of rabies virus by chemical agents]. Larghi OP; Savy VL; Nebel AE Rev Asoc Argent Microbiol; 1975; 7(3):86-90. PubMed ID: 1234351 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]